Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Instruments & Supplies
- Sub-Industry: Health Care Equipment
- Symbol: NASDAQ:IART
- CUSIP: 45798520
- Web: www.integralife.com
Capitalization:- Market Cap: $3.71 billion
- Outstanding Shares: 75,620,000
Average Prices:- 50 Day Moving Avg: $45.01
- 200 Day Moving Avg: $54.22
- 52 Week Range: $35.76 - $49.80
P/E:- Trailing P/E Ratio: 58.39
- Foreward P/E Ratio: 22.09
- P/E Growth: 2.22
Sales & Book Value:- Annual Revenue: $1.01 billion
- Price / Sales: 3.67
- Book Value: $11.33 per share
- Price / Book: 4.33
Profitability:- EBIDTA: $235.27 million
- Net Margins: 6.09%
- Return on Equity: 16.11%
- Return on Assets: 7.00%
Debt:- Debt-to-Equity Ratio: 0.80%
- Current Ratio: 3.17%
- Quick Ratio: 1.81%
Misc:- Average Volume: 573,073 shs.
- Beta: 0.8
- Short Ratio: 13.19
Frequently Asked Questions for Integra Lifesciences Holdings Corp (NASDAQ:IART)
What is Integra Lifesciences Holdings Corp's stock symbol?
Integra Lifesciences Holdings Corp trades on the NASDAQ under the ticker symbol "IART."
When did Integra Lifesciences Holdings Corp's stock split? How did Integra Lifesciences Holdings Corp's stock split work?
Integra Lifesciences Holdings Corp shares split on Tuesday, January 3rd 2017. The 2-1 split was announced on Thursday, December 22nd 2016. The newly issued shares were issued to shareholders after the market closes on Wednesday, December 21st 2016. An investor that had 100 shares of Integra Lifesciences Holdings Corp stock prior to the split would have 200 shares after the split.
How were Integra Lifesciences Holdings Corp's earnings last quarter?
Integra Lifesciences Holdings Corp (NASDAQ:IART) issued its quarterly earnings results on Wednesday, April, 26th. The company reported $0.39 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.40 by $0.01. The firm earned $258.60 million during the quarter, compared to the consensus estimate of $254.19 million. Integra Lifesciences Holdings Corp had a net margin of 6.09% and a return on equity of 16.11%. The business's revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.38 earnings per share. View Integra Lifesciences Holdings Corp's Earnings History.
What guidance has Integra Lifesciences Holdings Corp issued on next quarter's earnings?
Integra Lifesciences Holdings Corp issued an update on its FY17 earnings guidance on Wednesday, April, 26th. The company provided earnings per share guidance of $1.88-1.94 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.91. The company issued revenue guidance of $1.12-1.14 billion, compared to the consensus revenue estimate of $1.13 billion.
Where is Integra Lifesciences Holdings Corp's stock going? Where will Integra Lifesciences Holdings Corp's stock price be in 2017?
10 brokers have issued 12 month price objectives for Integra Lifesciences Holdings Corp's shares. Their predictions range from $42.00 to $54.00. On average, they anticipate Integra Lifesciences Holdings Corp's share price to reach $48.94 in the next year. View Analyst Ratings for Integra Lifesciences Holdings Corp.
Who are some of Integra Lifesciences Holdings Corp's key competitors?
Some companies that are related to Integra Lifesciences Holdings Corp include West Pharmaceutical Services (WST), Hill-Rom Holdings (HRC), ProShares UltraShort DJ-UBS Commodity (CMD), ICU Medical, Incorporated (ICUI), Insulet (PODD), Haemonetics (HAE), Inogen (INGN), Merit Medical Systems (MMSI), Halyard Health (HYH), Glaukos Corp (GKOS), Mazor Robotics Ltd - (MZOR), Luminex (LMNX), OraSure Technologies (OSUR), AtriCure (ATRC), AngioDynamics (ANGO), LeMaitre Vascular (LMAT), Endologix (ELGX) and Antares Pharma (ATRS).
Who owns Integra Lifesciences Holdings Corp stock?
Integra Lifesciences Holdings Corp's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include FMR LLC (10.07%), BlackRock Inc. (9.86%), Vanguard Group Inc. (7.48%), Champlain Investment Partners LLC (5.87%), Wells Fargo & Company MN (3.30%) and Janus Capital Management LLC (2.79%). Company insiders that own Integra Lifesciences Holdings Corp stock include Christian S Schade, Daniel L Reuvers, Glenn Coleman, James M Sullivan, Joseph Vinhais, Peter J Arduini, Raymond G Murphy, Richard D Gorelick and Stuart Essig. View Institutional Ownership Trends for Integra Lifesciences Holdings Corp.
Who sold Integra Lifesciences Holdings Corp stock? Who is selling Integra Lifesciences Holdings Corp stock?
Integra Lifesciences Holdings Corp's stock was sold by a variety of institutional investors in the last quarter, including Mesirow Financial Investment Management Equity Management and Capstone Asset Management Co.. Company insiders that have sold Integra Lifesciences Holdings Corp stock in the last year include Glenn Coleman, James M Sullivan, Peter J Arduini, Raymond G Murphy, Richard D Gorelick and Stuart Essig. View Insider Buying and Selling for Integra Lifesciences Holdings Corp.
Who bought Integra Lifesciences Holdings Corp stock? Who is buying Integra Lifesciences Holdings Corp stock?
Integra Lifesciences Holdings Corp's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc., Champlain Investment Partners LLC, FMR LLC, Janus Capital Management LLC, Dimensional Fund Advisors LP, State Street Corp and Eagle Asset Management Inc.. View Insider Buying and Selling for Integra Lifesciences Holdings Corp.
How do I buy Integra Lifesciences Holdings Corp stock?
Shares of Integra Lifesciences Holdings Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Integra Lifesciences Holdings Corp stock cost?
One share of Integra Lifesciences Holdings Corp stock can currently be purchased for approximately $49.05.
Earnings History for Integra Lifesciences Holdings Corp (NASDAQ:IART)Earnings History by Quarter for Integra Lifesciences Holdings Corp (NASDAQ:IART)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 4/26/2017 | Q1 17 | $0.40 | $0.39 | $254.19 million | $258.60 million | View | N/A |  |
| 2/23/2017 | Q4 2016 | $0.52 | $0.52 | $257.27 million | $255.70 million | View | N/A | |
| 10/27/2016 | Q3 | $0.89 | $0.93 | $249.30 million | $250.30 million | View | Listen | |
| 7/28/2016 | Q216 | $0.76 | $0.79 | $243.17 million | $249.30 million | View | Listen | |
| 4/27/2016 | Q116 | $0.73 | $0.74 | $230.66 million | $236.80 million | View | Listen | |
| 2/25/2016 | Q4 | $0.86 | $0.87 | $241.11 million | $241.20 million | View | Listen | |
| 11/3/2015 | Q315 | $0.74 | $0.75 | $224.08 million | $226.40 million | View | Listen | |
| 7/30/2015 | Q215 | $0.73 | $0.79 | $239.91 million | $244.10 million | View | Listen | |
| 4/30/2015 | Q115 | $0.63 | $0.76 | $229.69 million | $233.70 million | View | N/A | |
| 2/24/2015 | Q414 | $0.89 | $0.94 | $244.39 million | $252.20 million | View | Listen | |
| 11/3/2014 | Q314 | $0.74 | $0.76 | $233.50 million | $229.70 million | View | Listen | |
| 8/5/2014 | Q214 | $0.63 | $0.68 | $229.32 million | $231.40 million | View | N/A | |
| 5/1/2014 | Q114 | $0.58 | $0.57 | $213.30 million | $215.00 million | View | N/A | |
| 2/25/2014 | Q413 | $0.81 | $0.78 | $223.37 million | $220.80 million | View | N/A | |
| 10/28/2013 | Q313 | $0.70 | $0.72 | $214.05 million | $213.20 million | View | N/A | |
| 8/1/2013 | Q2 2013 | $0.55 | $0.60 | $207.30 million | $205.50 million | View | N/A | |
| 5/2/2013 | Q1 2013 | $0.37 | $0.39 | $195.20 million | $196.70 million | View | N/A | |
| 2/21/2013 | Q4 2012 | $0.76 | $0.78 | $215.90 million | $214.40 million | View | N/A | |
| 10/24/2012 | | $0.77 | $0.85 | | | View | N/A | |
| 7/26/2012 | | $0.69 | $0.74 | | | View | N/A | |
| 4/25/2012 | | $0.60 | $0.71 | | | View | N/A | |
| 2/23/2012 | | $0.55 | $0.72 | | | View | N/A | |
| 10/31/2011 | | $0.77 | $0.77 | | | View | N/A | |
| 7/28/2011 | | $0.61 | $0.70 | | | View | N/A | |
| 4/28/2011 | | $0.66 | $0.66 | | | View | N/A | |
| 2/24/2011 | | $0.73 | $0.80 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Integra Lifesciences Holdings Corp (NASDAQ:IART)2017 EPS Consensus Estimate: $1.92
2018 EPS Consensus Estimate: $2.26
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 4 | $0.38 | $0.48 | $0.42 |
| Q2 2017 | 4 | $0.43 | $0.47 | $0.45 |
| Q3 2017 | 4 | $0.42 | $0.52 | $0.49 |
| Q4 2017 | 4 | $0.54 | $0.60 | $0.57 |
| Q1 2018 | 2 | $0.46 | $0.51 | $0.49 |
| Q2 2018 | 2 | $0.51 | $0.55 | $0.53 |
| Q3 2018 | 2 | $0.57 | $0.57 | $0.57 |
| Q4 2018 | 2 | $0.65 | $0.70 | $0.68 |
(Data provided by Zacks Investment Research)
Dividend History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Integra Lifesciences Holdings Corp (NASDAQ:IART)Insider Ownership Percentage: 21.40%
Institutional Ownership Percentage: 44.37%
Insider Trades by Quarter for Integra Lifesciences Holdings Corp (NASDAQ:IART)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/25/2017 | Stuart Essig | Director | Sell | 135,000 | $49.90 | $6,736,500.00 | |
| 5/23/2017 | Stuart Essig | Director | Sell | 140,000 | $48.01 | $6,721,400.00 | |
| 5/4/2017 | Glenn Coleman | VP | Sell | 13,865 | $45.91 | $636,542.15 | |
| 5/4/2017 | James M Sullivan | Director | Sell | 15,658 | $45.89 | $718,545.62 | |
| 11/8/2016 | Peter J Arduini | CEO | Sell | 24,009 | $79.51 | $1,908,955.59 | |
| 8/23/2016 | Raymond G Murphy | Director | Sell | 2,600 | $86.64 | $225,264.00 | |
| 8/9/2016 | Peter J Arduini | CEO | Sell | 24,009 | $84.52 | $2,029,240.68 | |
| 8/4/2016 | Raymond G Murphy | Director | Sell | 2,610 | $84.83 | $221,406.30 | |
| 8/1/2016 | Richard D Gorelick | VP | Sell | 4,000 | $84.60 | $338,400.00 | |
| 5/9/2016 | Joseph Vinhais | VP | Sell | 972 | $73.36 | $71,305.92 | |
| 5/4/2016 | Glenn Coleman | CFO | Sell | 3,563 | $70.62 | $251,619.06 | |
| 5/3/2016 | Christian S Schade | Director | Sell | 7,829 | $70.42 | $551,318.18 | |
| 5/2/2016 | Daniel L Reuvers | VP | Sell | 1,000 | $71.43 | $71,430.00 | |
| 4/29/2016 | Richard D Gorelick | VP | Sell | 4,000 | $70.72 | $282,880.00 | |
| 4/27/2016 | Stuart Essig | Director | Sell | 104,390 | $70.15 | $7,322,958.50 | |
| 4/6/2016 | Stuart Essig | Director | Sell | 21,100 | $66.19 | $1,396,609.00 | |
| 4/5/2016 | Stuart Essig | Director | Sell | 83,290 | $66.68 | $5,553,777.20 | |
| 4/4/2016 | Stuart Essig | Director | Sell | 42,150 | $67.26 | $2,835,009.00 | |
| 5/7/2015 | Stuart Essig | Director | Sell | 75,000 | $64.32 | $4,824,000.00 | |
| 5/6/2015 | Stuart Essig | Director | Sell | 125,000 | $64.83 | $8,103,750.00 | |
| 1/2/2015 | Judith Ogrady | VP | Sell | 3,500 | $53.33 | $186,655.00 | |
| 10/28/2014 | Stuart Essig | Director | Sell | 147,098 | $49.58 | $7,293,118.84 | |
| 10/27/2014 | Stuart Essig | Director | Sell | 41,268 | $49.56 | $2,045,242.08 | |
| 9/2/2014 | Judith Ogrady | VP | Sell | 2,500 | $49.82 | $124,550.00 | |
| 8/27/2014 | Richard D Gorelick | VP | Sell | 7,000 | $50.03 | $350,210.00 | |
| 8/25/2014 | John B Henneman III | CAO | Sell | 20,000 | $50.12 | $1,002,400.00 | |
| 8/22/2014 | Deborah A Leonetti | VP | Sell | 1,000 | $50.96 | $50,960.00 | |
| 8/8/2014 | Brian Larkin | VP | Sell | 1,947 | $48.28 | $94,001.16 | |
| 7/30/2014 | Stuart Essig | Director | Sell | 50,800 | $47.76 | $2,426,208.00 | |
| 7/23/2014 | Stuart Essig | Director | Sell | 27,819 | $47.80 | $1,329,748.20 | |
| 7/1/2014 | Judith Ogrady | VP | Sell | 2,500 | $47.54 | $118,850.00 | |
| 6/23/2014 | Stuart Essig | Director | Sell | 21,381 | $47.76 | $1,021,156.56 | |
| 4/3/2014 | Stuart Essig | Director | Sell | 6,344 | $46.01 | $291,887.44 | |
| 4/2/2014 | Stuart Essig | Director | Sell | 76,177 | $46.05 | $3,507,950.85 | |
| 3/31/2014 | Stuart Essig | Director | Sell | 17,479 | $46.05 | $804,907.95 | |
| 3/10/2014 | Deborah Leonetti | VP | Sell | 7,563 | $49.22 | $372,250.86 | |
| 3/4/2014 | Richard Gorelick | VP | Sell | 2,000 | $47.98 | $95,960.00 | |
| 2/28/2014 | Christian Schade | Director | Sell | 7,500 | $47.06 | $352,950.00 | |
| 2/27/2014 | Brian Larkin | VP | Sell | 3,265 | $46.15 | $150,679.75 | |
| 2/27/2014 | John Henneman III | CFO | Sell | 5,000 | $46.07 | $230,350.00 | |
| 1/16/2014 | Stuart Essig | Director | Sell | 8,037 | $49.59 | $398,554.83 | |
| 1/14/2014 | Stuart Essig | Director | Sell | 10,600 | $49.50 | $524,700.00 | |
| 1/13/2014 | Stuart Essig | Director | Sell | 99,032 | $49.51 | $4,903,074.32 | |
| 1/9/2014 | Stuart Essig | Director | Sell | 114,431 | $49.58 | $5,673,488.98 | |
| 8/30/2013 | Richard Gorelick | VP | Sell | 3,000 | $40.79 | $122,370.00 | |
| 8/23/2013 | Deborah Leonetti | VP | Sell | 8,906 | $41.68 | $371,202.08 | |
| 8/19/2013 | Brian Larkin | VP | Sell | 7,490 | $41.90 | $313,831.00 | |
| 8/19/2013 | John Henneman III | CFO | Sell | 30,000 | $42.08 | $1,262,400.00 | |
| 8/1/2013 | Judith Ogrady | VP | Sell | 1,000 | $39.50 | $39,500.00 | |
| 7/30/2013 | Judith Ogrady | VP | Sell | 2,000 | $38.50 | $77,000.00 | |
| 5/31/2013 | Jerry E Corbin | VP | Sell | 1,876 | $38.07 | $71,419.32 | |
(Data available from 1/1/2013 forward)
Headline Trends for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Latest Headlines for Integra Lifesciences Holdings Corp (NASDAQ:IART)
| Source: |
|
| Date | Headline |
|---|
 | Integra Lifesciences Holdings Corp (IART) Director Stuart Essig Sells 135,000 Shares
www.americanbankingnews.com - May 26 at 7:26 PM |
| Integra Lifesciences Holdings Corp (IART) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 26 at 2:53 PM |
| Integra Lifesciences Holdings Corp (IART) Director Sells $6,721,400.00 in Stock
www.americanbankingnews.com - May 24 at 7:21 PM |
 | Integra LifeSciences to Offer aap's LOQTEQ System in the US
www.nasdaq.com - May 24 at 5:40 PM |
 | Integra LifeSciences to Present at Healthcare Conferences in June 2017
finance.yahoo.com - May 24 at 5:40 PM |
| ValuEngine Lowers Integra Lifesciences Holdings Corp (IART) to Hold
www.americanbankingnews.com - May 23 at 5:04 PM |
 | BRIEF-Integra Lifesciences Holdings Corp signs an agreement with AAP Implantate AG
www.reuters.com - May 23 at 11:24 AM |
| Integra LifeSciences Announces Agreement with aap to Distribute LOQTEQ® Distal Radius System
finance.yahoo.com - May 23 at 11:24 AM |
| Integra LifeSciences Announces the European Launch of Integra® Dermal Regeneration Template Single Layer "Thin"
finance.yahoo.com - May 17 at 10:04 AM |
| Integra Lifesciences Holdings Corp (IART) Given a $54.00 Price Target by Oppenheimer Holdings Inc. Analysts
www.americanbankingnews.com - May 15 at 2:34 PM |
| Integra LifeSciences launches SurgiMend® MP Collagen Matrix for Hernia Repair
finance.yahoo.com - May 12 at 6:30 PM |
| ETFs with exposure to Integra LifeSciences Holdings Corp. : May 11, 2017
finance.yahoo.com - May 11 at 6:23 PM |
| Analysts Anticipate Integra Lifesciences Holdings Corp (IART) Will Post Quarterly Sales of $282.89 Million
www.americanbankingnews.com - May 6 at 8:47 AM |
| Insider Selling: Integra Lifesciences Holdings Corp (IART) Director Sells 15,658 Shares of Stock
www.americanbankingnews.com - May 5 at 8:11 PM |
| Integra Lifesciences Holdings Corp (IART) VP Sells $636,542.15 in Stock
www.americanbankingnews.com - May 5 at 8:11 PM |
| Analysts Anticipate Integra Lifesciences Holdings Corp (IART) to Post $0.44 Earnings Per Share
www.americanbankingnews.com - May 4 at 1:24 PM |
| Integra LifeSciences to Present at Healthcare Conferences in May 2017
finance.yahoo.com - May 3 at 5:26 PM |
| Positive Media Coverage Very Likely to Impact Integra Lifesciences Holdings Corp (IART) Stock Price
www.americanbankingnews.com - May 2 at 6:10 PM |
| Integra Lifesciences Holdings Corp (IART) Given New $48.00 Price Target at Royal Bank of Canada
www.americanbankingnews.com - May 2 at 7:54 AM |
| Integra Lifesciences Holdings Corp (IART) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 1 at 6:38 PM |
| Jefferies Group Comments on Integra Lifesciences Holdings Corp's Q4 2017 Earnings (IART)
www.americanbankingnews.com - May 1 at 11:34 AM |
| Q2 2017 EPS Estimates for Integra Lifesciences Holdings Corp Raised by Northcoast Research (IART)
www.americanbankingnews.com - May 1 at 8:11 AM |
| Favorable Press Coverage Likely to Impact Integra Lifesciences Holdings Corp (IART) Stock Price
www.americanbankingnews.com - April 29 at 8:50 PM |
| Integra Lifesciences Holdings Corp (IART) Given Buy Rating at Jefferies Group LLC
www.americanbankingnews.com - April 29 at 1:05 AM |
| Integra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q1, 2017 By the Numbers : April 28, 2017
finance.yahoo.com - April 28 at 6:46 PM |
| Jefferies Group Analysts Raise Earnings Estimates for Integra Lifesciences Holdings Corp (IART)
www.americanbankingnews.com - April 28 at 1:25 PM |
| Integra Lifesciences Holdings Corp (IART) Forecasted to Post Q2 2017 Earnings of $0.44 Per Share
www.americanbankingnews.com - April 28 at 7:54 AM |
| Edited Transcript of IART earnings conference call or presentation 26-Apr-17 12:30pm GMT
finance.yahoo.com - April 27 at 6:24 PM |
 | Integra LifeSciences (IART) Misses Q1 Earnings, Retains View
www.zacks.com - April 27 at 8:33 AM |
 | Integra Lifesciences Holdings Corp Announces 9% Advance In Q1 Profit
www.rttnews.com - April 26 at 7:30 PM |
 | Integra LifeSciences Holdings Corporation 2017 Q1 - Results - Earnings Call Slides
seekingalpha.com - April 26 at 7:30 PM |
| Integra LifeSciences Reports First Quarter 2017 Financial Results
finance.yahoo.com - April 26 at 7:30 PM |
| Integra misses 1Q profit forecasts
finance.yahoo.com - April 26 at 7:30 PM |
| Integra Lifesciences Holdings Corp (IART) Receives Coverage Optimism Score of 0.06
www.americanbankingnews.com - April 26 at 12:53 PM |
| Integra Lifesciences Holdings Corp (IART) Issues Earnings Results
www.americanbankingnews.com - April 26 at 12:18 PM |
| Integra LifeSciences Holdings Corp. – Value Analysis (NASDAQ:IART) : April 24, 2017
finance.yahoo.com - April 24 at 5:29 PM |
| Integra Lifesciences Holdings Corp (IART) Getting Favorable Press Coverage, Analysis Finds
www.americanbankingnews.com - April 23 at 8:45 AM |
| Integra LifeSciences Holdings Corp. breached its 50 day moving average in a Bullish Manner : IART-US : April 21, 2017
finance.yahoo.com - April 21 at 10:50 AM |
| Somewhat Positive Press Coverage Extremely Likely to Affect Integra Lifesciences Holdings Corp (IART) Stock Price
www.americanbankingnews.com - April 18 at 12:15 AM |
| Integra LifeSciences' Stock Split: Why It Accomplished Nothing
finance.yahoo.com - April 15 at 5:03 PM |
| Integra Lifesciences Holdings Corp (IART) Expected to Post Quarterly Sales of $254.75 Million
www.americanbankingnews.com - April 15 at 8:58 AM |
| Brokerages Expect Integra Lifesciences Holdings Corp (IART) Will Announce Earnings of $0.40 Per Share
www.americanbankingnews.com - April 13 at 1:06 PM |
 | Integra LifeSciences to Host Its First Quarter 2017 Earnings Results ...
globenewswire.com - April 12 at 5:57 PM |
| Integra LifeSciences to Host Its First Quarter 2017 Earnings Results Conference Call on April 26, 2017
finance.yahoo.com - April 12 at 5:57 PM |
| Integra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan
finance.yahoo.com - April 7 at 10:20 AM |
| Integra Lifesciences Holdings Corp (IART) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - April 4 at 2:07 PM |
| Why One Analyst Sees Almost 40% Upside in Integra LifeSciences
finance.yahoo.com - April 3 at 3:19 PM |
| BRIEF-Integra Lifesciences announces commercial expansion of Cadence Total Ankle System
www.reuters.com - March 29 at 10:42 AM |
| Integra Lifesciences Holdings Corp Forecasted to Earn Q1 2017 Earnings of $0.48 Per Share (IART)
www.americanbankingnews.com - March 29 at 10:29 AM |
| Integra LifeSciences Announces Commercial Expansion of the Cadence® Total Ankle System
finance.yahoo.com - March 28 at 11:19 AM |
Integra Lifesciences Holdings Corp (IART) Chart for Saturday, May, 27, 2017
